Evidence for a CLL cell-intrinsic IFN signaling defect was described earlier in this review with low expression of IRF4 associated with inferior prognosis and associated studies supporting a novel tumor immune evasion mechanism (148). The gene discussed is IFNA1; the disease is neoplasm.